C Mulatero
Overview
Explore the profile of C Mulatero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Califano R, Tariq N, Compton S, Fitzgerald D, Harwood C, Lal R, et al.
Drugs
. 2015 Jul;
75(12):1335-48.
PMID: 26187773
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib, erlotinib, and afatinib are standard-of-care for first-line treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). These drugs...
2.
Molassiotis A, Brunton L, Hodgetts J, Green A, Beesley V, Mulatero C, et al.
Ann Oncol
. 2014 Aug;
25(10):2052-2058.
PMID: 25081900
Background: Knowledge about supportive care needs in patients with cutaneous invasive melanoma is scarce. We examined the unmet needs of melanoma patients treated with surgery and factors associated with these...
3.
Besse B, Heist R, Papadmitrakopoulou V, Camidge D, Beck J, Schmid P, et al.
Ann Oncol
. 2013 Dec;
25(2):505-11.
PMID: 24368401
Background: This phase Ib study aimed to establish the feasible everolimus dose given with standard-dose etoposide plus cisplatin (EP) for extensive-stage small-cell lung cancer (SCLC). Patients And Methods: An adaptive...
4.
Ford J, Cummins E, Sharma P, Elders A, Stewart F, Johnston R, et al.
Health Technol Assess
. 2013 Jul;
17(29):1-386.
PMID: 23870108
Background: Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours. Objectives: The aim of this review was...
5.
Mulatero C, McClaren B, Mason M, Oliver R, Gallagher C
Br J Cancer
. 2000 Dec;
83(12):1612-6.
PMID: 11104554
A phase II study to evaluate the efficacy and toxicity of the combination of vinblastine, paclitaxel and cisplatin (PVC) in previously untreated patients with advanced transitional cell carcinoma. Chemotherapy naive...
6.
Mulatero C, Brogan G, Oliver R
Postgrad Med J
. 2000 Mar;
76(894):234-6.
PMID: 10727571
A case of fulminating deep venous thrombosis secondary to invasion of the inferior vena cava is described in a 45 year old man presenting with a germ cell tumour. Despite...
7.
Papamichael D, Norton A, Foran J, Mulatero C, Mathews J, Amess J, et al.
J Clin Oncol
. 1999 Nov;
17(9):2847-53.
PMID: 10561361
Purpose: To analyze the presentation features and outcome for patients with immunocytoma (IMC) managed at St Bartholomew's Hospital (SBH), London, United Kingdom, between 1972 and 1996. Outcome was compared with...
8.
Mulatero C, Surentheran T, Breuer J, Rudd R
Thorax
. 1999 May;
54(1):60-1.
PMID: 10343634
Background: An aetiological role for Simian virus 40 (SV40) in malignant mesothelioma has been suggested from studies in the USA and the UK but results have been conflicting. A study...